119 filings
Page 3 of 6
8-K
1a4m a5g9eo8igq
7 Jan 21
Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference
4:14pm
8-K
0rqu e99ir
31 Dec 20
Other Events
4:05pm
8-K
w032vnu5vrq ncnn
16 Dec 20
Departure of Directors or Certain Officers
7:00am
8-K
04s1kv
27 Nov 20
Entry into a Material Definitive Agreement
7:38am
8-K
v8wd2
5 Nov 20
Sage Therapeutics Announces Third Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
8-K
rc17z8c9mbxvdw
15 Oct 20
Sage Therapeutics Announces Positive Interim, Topline Zuranolone
9:14am
8-K
phm0rpe73ea7tl6rq86
1 Oct 20
Sage Therapeutics Appoints Barry Greene to Board of Directors
4:05pm
8-K
2eziw59cgrcnnnui
10 Aug 20
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
8-K
148 ljod8t
10 Jun 20
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
socct
7 May 20
Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
4:27pm
8-K
u1xdh7r jy25196y
7 Apr 20
Sage Therapeutics Announces Restructuring to Advance Corporate Strategy and Pipeline
4:25pm
8-K
zr0q4ko h3gryi6ulh40
18 Mar 20
Sage Therapeutics Announces Development Plan for Zuranolone(SAGE-217) Following
6:57am
8-K
8gx9cx
27 Feb 20
Sage Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
0l4hnbki
5 Dec 19
Sage Therapeutics Reports Topline Results from Pivotal Phase 3
7:01am
8-K
bap0v8ox
12 Nov 19
Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights
6:44am
8-K
u6ngm7
6 Aug 19
Results of Operations and Financial Condition
7:04am
8-K
8q5vfp26br5
24 Jul 19
Sage Therapeutics Announces Clinical Updates and Progress Across Neuroscience Pipeline
7:18am
8-K
4o2ebk
14 Jun 19
Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSOâ„¢ (brexanolone) Injection
9:03am
8-K
8og0ef6
6 Jun 19
Submission of Matters to a Vote of Security Holders
4:36pm
8-K
3ltiq n9vvir9vfnsx
2 May 19
Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
7:25am